Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

R&D Expenses

$993.80M

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX R&D Expenses

Latest reported$993.80Mperiod endingJun 30, 2026

Latest reported$993.80Mperiod endingJun 30, 2026

VRTX Quarterly R&D Expenses ($0.00 → $993.80M)

Quarterly R&D Expenses

High-resolution chart · PNG

VRTX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	27,794,000
Mar 31, 2001	26,119,000
Dec 31, 2000	25,145,000
Sep 30, 2000	21,348,000
Jun 30, 2000	19,824,000
Mar 31, 2000	18,604,000
Dec 31, 1999	18,100,000
Sep 30, 1999	16,400,000
Jun 30, 1999	19,000,000
Mar 31, 1999	18,600,000
Dec 31, 1998	18,100,000
Sep 30, 1998	15,700,000
Jun 30, 1998	12,600,000
Mar 31, 1998	12,200,000
Dec 31, 1997	14,000,000
Sep 30, 1997	16,400,000
Jun 30, 1997	10,800,000
Mar 31, 1997	10,300,000
Dec 31, 1996	7,900,000
Sep 30, 1996	8,500,000
Jun 30, 1996	9,500,000
Mar 31, 1996	9,300,000
Dec 31, 1995	8,400,000
Sep 30, 1995	8,600,000
Jun 30, 1995	15,100,000
Mar 31, 1995	9,400,000
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.